Antithrombotic management during percutaneous mechanical circulatory support: defining the status quo, before agreeing quo vadis

Eur Heart J Acute Cardiovasc Care. 2024 Jun 30;13(6):470-471. doi: 10.1093/ehjacc/zuae056.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Fibrinolytic Agents* / therapeutic use
  • Heart Failure / surgery
  • Heart Failure / therapy
  • Heart-Assist Devices*
  • Humans
  • Thrombosis / prevention & control

Substances

  • Fibrinolytic Agents